Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

In Reply: Wilson disease.

Hanouneh MA, Garber A, Tavill AS, Zein NN, Hanouneh IA.

Cleve Clin J Med. 2016 Jun;83(6):406-7. doi: 10.3949/ccjm.83c.06002. No abstract available.

2.

A tale of two sisters with liver disease.

Hanouneh MA, Garber A, Tavill AS, Zein NN, Hanouneh IA.

Cleve Clin J Med. 2016 Feb;83(2):109-15. doi: 10.3949/ccjm.83a.15048. No abstract available.

3.

Concomitant presentation of collagenous sprue and HFE hemochromatosis.

Parisian KR, Plesec TP, Fairbanks KD, Tavill AS, Shen B.

J Crohns Colitis. 2011 Aug;5(4):369-72. doi: 10.1016/j.crohns.2011.03.009. Epub 2011 Apr 29.

PMID:
21683310
4.

Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases.

Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS; American Association for the Study of Liver Diseases.

Hepatology. 2011 Jul;54(1):328-43. doi: 10.1002/hep.24330. No abstract available.

5.

Liver disease in alpha 1-antitrypsin deficiency: a review.

Fairbanks KD, Tavill AS.

Am J Gastroenterol. 2008 Aug;103(8):2136-41; quiz 2142. doi: 10.1111/j.1572-0241.2008.01955.x. Review.

PMID:
18796107
6.

Arthur Joseph McCullough, Jr., 58th President, AASLD.

Czaja AJ, Tavill AS.

Hepatology. 2008 Mar;47(3):775-6. doi: 10.1002/hep.22666. No abstract available.

PMID:
18306226
7.

A diagnostic approach to hemochromatosis.

Tavill AS, Adams PC.

Can J Gastroenterol. 2006 Aug;20(8):535-40. Review.

8.

Pegylated interferon alpha-2b, ribavirin and amantadine for chronic hepatitis C.

Younossi ZM, McCullough AC, Barnes DS, Post A, Ong JP, O'Shea R, Martin LM, Bringman D, Farmer D, Levinthal G, Mullen KD, Carey WD, Tavill AS, Ferguson R, Gramlich T.

Dig Dis Sci. 2005 May;50(5):970-5.

PMID:
15906777
9.

Alcohol and iron.

Tavill AS, Qadri AM.

Semin Liver Dis. 2004 Aug;24(3):317-25. Review.

PMID:
15349808
10.

Connective tissue diseases and the liver.

Youssef WI, Tavill AS.

J Clin Gastroenterol. 2002 Oct;35(4):345-9. Review.

PMID:
12352299
11.

Hepatitis C and human immunodeficiency virus coinfections.

Dodig M, Tavill AS.

J Clin Gastroenterol. 2001 Nov-Dec;33(5):367-74. Review.

PMID:
11606851
12.

Diagnosis and management of hemochromatosis.

Tavill AS; American Association for the Study of Liver Diseases; American College of Gastroenterology; American Gastroenterological Association.

Hepatology. 2001 May;33(5):1321-8. No abstract available.

PMID:
11343262
13.

Wilson's Disease.

Tavill AS, Schilsky ML.

Curr Treat Options Gastroenterol. 1999 Feb;2(1):68-71.

PMID:
11096575
14.

Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial.

Di Bisceglie AM, Bonkovsky HL, Chopra S, Flamm S, Reddy RK, Grace N, Killenberg P, Hunt C, Tamburro C, Tavill AS, Ferguson R, Krawitt E, Banner B, Bacon BR.

Hepatology. 2000 Jul;32(1):135-8.

PMID:
10869301
15.

Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial.

Fontana RJ, Israel J, LeClair P, Banner BF, Tortorelli K, Grace N, Levine RA, Fiarman G, Thiim M, Tavill AS, Bonkovsky HL.

Hepatology. 2000 Mar;31(3):730-6.

16.

Clinical implications of the hemochromatosis gene.

Tavill AS.

N Engl J Med. 1999 Sep 2;341(10):755-7. No abstract available.

PMID:
10471465
17.

Screening for hemochromatosis: phenotyping or genotyping or both?

Tavill AS.

Am J Gastroenterol. 1999 Jun;94(6):1430-3. Review. No abstract available.

PMID:
10364003
18.

Nonalcoholic fatty liver (NASH syndrome).

O'Connor BJ, Kathamna B, Tavill AS.

Gastroenterologist. 1997 Dec;5(4):316-29. Review.

PMID:
9436007
19.

Primary prophylaxis of variceal bleeding in cirrhosis: a cost-effectiveness analysis.

Teran JC, Imperiale TF, Mullen KD, Tavill AS, McCullough AJ.

Gastroenterology. 1997 Feb;112(2):473-82.

PMID:
9024301
20.

An update on iron metabolism: summary of the Fifth International Conference on Disorders of Iron Metabolism.

Bonkovsky HL, Ponka P, Bacon BR, Drysdale J, Grace ND, Tavill AS.

Hepatology. 1996 Sep;24(3):718-29.

PMID:
8781349
21.

A 49-year-old man with alpha 1-antitrypsin deficiency and abnormal iron study results.

Brunt EM, Tavill AS, Bacon BR.

Semin Liver Dis. 1996 Feb;16(1):97-101. No abstract available.

PMID:
8723327
22.

An oral treatment for iron overload in thalassemia?

Kowdley KV, Tavill AS.

Hepatology. 1996 Feb;23(2):380-2. No abstract available.

PMID:
8591869
23.

Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis.

Kowdley KV, Hassanein T, Kaur S, Farrell FJ, Van Thiel DH, Keeffe EB, Sorrell MF, Bacon BR, Weber FL Jr, Tavill AS.

Liver Transpl Surg. 1995 Jul;1(4):237-41.

24.

Monitoring alcoholic liver injury.

Quinn PG, Teran JC, Tavill AS.

Contemp Intern Med. 1994 Jun;6(6):56-62, 67-72. Review.

PMID:
10150368
25.

Terbutaline hepatitis in pregnancy: report of two cases and literature review.

Quinn PG, Sherman BW, Tavill AS, Gibas AL.

Am J Gastroenterol. 1994 May;89(5):781-4. Review. No abstract available.

PMID:
8172156
26.

The Budd-Chiari syndrome revisited.

Shill M, Henderson JM, Tavill AS.

Gastroenterologist. 1994 Mar;2(1):27-38. Review.

PMID:
8055228
27.

Disulfide bond formation between dimeric immunoglobulin A and the polymeric immunoglobulin receptor during hepatic transcytosis.

Chintalacharuvu KR, Tavill AS, Louis LN, Vaerman JP, Lamm ME, Kaetzel CS.

Hepatology. 1994 Jan;19(1):162-73.

PMID:
8276353
28.

Orthotopic liver transplantation in two adults with Niemann-Pick and Gaucher's diseases: implications for the treatment of inherited metabolic disease.

Smanik EJ, Tavill AS, Jacobs GH, Schafer IA, Farquhar L, Weber FL Jr, Mayes JT, Schulak JA, Petrelli M, Zirzow GC, et al.

Hepatology. 1993 Jan;17(1):42-9.

PMID:
8423040
29.

An "ironic" case of mistaken identity?

Kowdley KV, Tavill AS.

Hepatology. 1992 Aug;16(2):500-1. No abstract available.

PMID:
1639360
30.

In vivo differences between the turnover rates of leucine and leucine's ketoacid in stable cirrhosis.

McCullough AJ, Mullen KD, Tavill AS, Kalhan SC.

Gastroenterology. 1992 Aug;103(2):571-8.

PMID:
1634076
31.

Disordered energy and protein metabolism in liver disease.

McCullough AJ, Tavill AS.

Semin Liver Dis. 1991 Nov;11(4):265-77. Review.

PMID:
1763333
32.

Iron and the liver: genetic hemochromatosis and other hepatic iron overload disorders.

Tavill AS, Sharma BK, Bacon BR.

Prog Liver Dis. 1990;9:281-305. Review. No abstract available.

PMID:
2156297
33.

Corticosteroids in severe alcoholic hepatitis.

Black M, Tavill AS.

Ann Intern Med. 1989 May 1;110(9):677-80. Review. No abstract available.

PMID:
2648926
34.

Lipid peroxidation in experimental hemochromatosis.

Bacon BR, Brittenham GM, Park CH, Tavill AS.

Ann N Y Acad Sci. 1988;526:155-63. Review. No abstract available.

PMID:
3291680
35.

Pathology of dietary carbonyl iron overload in rats.

Park CH, Bacon BR, Brittenham GM, Tavill AS.

Lab Invest. 1987 Nov;57(5):555-63.

PMID:
3682765
36.

Should all pregnant women be screened for hepatitis B?

Kumar ML, Dawson NV, McCullough AJ, Radivoyevitch M, King KC, Hertz R, Kiefer H, Hampson M, Cassidy R, Tavill AS.

Ann Intern Med. 1987 Sep;107(3):273-7.

PMID:
3619218
37.

Leucine metabolism in stable cirrhosis.

Mullen KD, Denne SC, McCullough AJ, Savin SM, Bruno D, Tavill AS, Kalhan SC.

Hepatology. 1986 Jul-Aug;6(4):622-30.

PMID:
3089896
38.

Hepatic microsomal function in rats with chronic dietary iron overload.

Bacon BR, Healey JF, Brittenham GM, Park CH, Nunnari J, Tavill AS, Bonkovsky HL.

Gastroenterology. 1986 Jun;90(6):1844-53.

PMID:
3009259
39.

Immediate diagnostic criteria for bacterial infection of ascitic fluid. Evaluation of ascitic fluid polymorphonuclear leukocyte count, pH, and lactate concentration, alone and in combination.

Stassen WN, McCullough AJ, Bacon BR, Gutnik SH, Wadiwala IM, McLaren C, Kalhan SC, Tavill AS.

Gastroenterology. 1986 May;90(5 Pt 1):1247-54.

PMID:
3956943
40.

Hemochromatosis: how much iron is too much?

Tavill AS, Bacon BR.

Hepatology. 1986 Jan-Feb;6(1):142-5. No abstract available.

PMID:
3943779
41.

Hepatic mitochondrial oxidative metabolism in rats with chronic dietary iron overload.

Bacon BR, Park CH, Brittenham GM, O'Neill R, Tavill AS.

Hepatology. 1985 Sep-Oct;5(5):789-97.

PMID:
4029891
42.

Intracellular pathways of protein synthesis and secretion in the hepatocyte.

Tavill AS.

Semin Liver Dis. 1985 May;5(2):95-109. Review.

PMID:
3895440
43.

Role of the liver in normal iron metabolism.

Bacon BR, Tavill AS.

Semin Liver Dis. 1984 Aug;4(3):181-92. Review.

PMID:
6385267
44.
45.

CT-guided percutaneous catheter drainage of lymphocele complicating splenorenal anastomosis.

Vibhakar SD, Lee H, Schreiber H, Kolozsi WZ, Tavill AS.

Dig Dis Sci. 1983 Nov;28(11):1043-6.

PMID:
6628152
46.

Synthesis and release of Hageman factor (Factor XII) by the isolated perfused rat liver.

Saito H, Hamilton SM, Tavill AS, Goodnough LT, Louis L, Angell A.

J Clin Invest. 1983 Sep;72(3):948-54.

47.

Branched-chain amino acids as nutritional therapy in liver disease: dearth or surfeit?

McCullough AJ, Mullen KD, Tavill AS.

Hepatology. 1983 Mar-Apr;3(2):269-71. No abstract available.

PMID:
6832718
48.

Hepatic lipid peroxidation in vivo in rats with chronic iron overload.

Bacon BR, Tavill AS, Brittenham GM, Park CH, Recknagel RO.

J Clin Invest. 1983 Mar;71(3):429-39.

49.

Hepatic lipid peroxidation in vivo in rats with chronic dietary iron overload is dependent on hepatic iron concentration.

Bacon BR, Brittenham GM, Tavill AS, McLaren CE, Park CH, Recknagel RO.

Trans Assoc Am Physicians. 1983;96:146-54. No abstract available.

PMID:
6679952
50.

Renal lipidosis associated with arteriohepatic dysplasia (Alagille's syndrome).

Chung-Park M, Petrelli M, Tavill AS, Hall PW 3rd, Henoch MS, Dahms BB.

Clin Nephrol. 1982 Dec;18(6):314-20.

PMID:
7151349

Supplemental Content

Loading ...
Support Center